The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp1186
Q&A
Date
May 9, 2023
Explore related products in the following collection:
Symptoms such as intractable pruritus, cramping and fatigue are the most impactful to a patients quality of life and often the most challenging manage. This session provides expert guidance in helping patients with these issues.
Symptoms such as intractable pruritus, cramping and fatigue are the most impactful to a patients quality of life and often the most challenging manage. This session provides expert guidance in helping patients with these issues…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Symptoms such as intractable pruritus, cramping and fatigue are the most impactful to a patients quality of life and often the most challenging manage. This session provides expert guidance in helping patients with these issues…